After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
A new randomized clinical trial from investigators at Mass General Brigham’s Neuroscience Institute and Department of ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of ...
The products are far from a proven sleep treatment.
High-dose DHA effectively increased brain levels in older adults at Alzheimer's risk, but did not lead to cognitive or ...
By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than eight million deaths ...
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
Morning Overview on MSN
People on Ozempic-style drugs quietly started moving less, a Fitbit study found
Adults who started taking GLP-1 receptor agonist drugs such as semaglutide logged fewer daily steps and less time exercising ...
Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results